Lifecore Biomedical Inc (LFCR)
6.40
-0.28
(-4.19%)
USD |
NASDAQ |
Nov 15, 16:00
6.41
+0.01
(+0.16%)
After-Hours: 20:00
Lifecore Biomedical Research and Development Expense (TTM): 8.615M for Aug. 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| August 31, 2024 | 8.615M |
| May 31, 2024 | 8.575M |
| February 29, 2024 | 8.529M |
| November 30, 2023 | 8.593M |
| August 31, 2023 | 8.672M |
| May 31, 2023 | 8.737M |
| February 28, 2023 | 8.739M |
| November 30, 2022 | 8.505M |
| August 31, 2022 | 8.184M |
| May 31, 2022 | 7.846M |
| February 28, 2022 | 6.89M |
| November 30, 2021 | 6.733M |
| August 31, 2021 | 7.449M |
| May 31, 2021 | 8.084M |
| February 28, 2021 | 6.115M |
| November 30, 2020 | 7.019M |
| August 31, 2020 | 7.269M |
| May 31, 2020 | 7.582M |
| February 29, 2020 | 11.85M |
| November 30, 2019 | 11.84M |
| August 31, 2019 | 11.50M |
| May 31, 2019 | 11.47M |
| February 28, 2019 | 11.60M |
| November 30, 2018 | 11.98M |
| August 31, 2018 | 12.87M |
| Date | Value |
|---|---|
| May 31, 2018 | 12.80M |
| February 28, 2018 | 12.76M |
| November 30, 2017 | 11.66M |
| August 31, 2017 | 10.25M |
| May 31, 2017 | 9.473M |
| February 28, 2017 | 7.732M |
| November 30, 2016 | 7.613M |
| August 31, 2016 | 7.291M |
| May 31, 2016 | 7.228M |
| February 29, 2016 | 7.026M |
| November 30, 2015 | 6.886M |
| August 31, 2015 | 7.068M |
| May 31, 2015 | 6.988M |
| February 28, 2015 | 7.011M |
| November 30, 2014 | 6.979M |
| August 31, 2014 | 7.073M |
| May 31, 2014 | 7.204M |
| February 28, 2014 | 8.22M |
| November 30, 2013 | 8.822M |
| August 31, 2013 | 9.016M |
| May 31, 2013 | 9.294M |
| February 28, 2013 | 9.125M |
| November 30, 2012 | 9.273M |
| August 31, 2012 | 9.497M |
| May 31, 2012 | 9.626M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
6.115M
Minimum
Feb 2021
11.85M
Maximum
Feb 2020
8.292M
Average
8.344M
Median
Research and Development Expense (TTM) Benchmarks
| AngioDynamics Inc | 29.86M |
| Precision Optics Corp Inc | 0.9818M |
| Sage Therapeutics Inc | 253.20M |
| Outset Medical Inc | 43.04M |
| NovaBay Pharmaceuticals Inc | 0.064M |